Advertisement

COVID-19 Vaccine Delay: Buy These Stocks to Safeguard Your Portfolio

COVID-19 Vaccine Delay: Buy These Stocks to Safeguard Your Portfolio

According to the Centers for Disease Control and Prevention, there are 170 vaccine candidates in development around the world. One of the more promising companies conducting trials, AstraZeneca (NYSE: AZN), had to temporarily pause its trial on Sept. 8 after a woman injected with its vaccine experienced an illness. AstraZeneca paused its vaccine trial.